During the past decade, Vanderbilt University conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 149 clinical trials were completed, i.e. on average, 65.6% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 71 clinical trials were completed. i.e. 95.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt University" #1 sponsor was "Vanderbilt University" with 112 trials, followed by "Vanderbilt University Medical Center" with 37 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 28 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 10 trials sponsored and "National Cancer Institute (NCI)" with 10 trials sponsored. Other sponsors include 352 different institutions and companies that sponsored additional 235 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt University" #1 collaborator was "Vanderbilt University" with 50 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 39 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 15 trials as a collaborator, "National Institutes of Health (NIH)" with 15 trials as a collaborator and "National Cancer Institute (NCI)" with 13 trials as a collaborator. Other collaborators include 649 different institutions and companies that were collaborators in the rest 366 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt University" are "Influenza" (15 trials), "Hypertension" (12 trials), "Obesity" (12 trials), "Multiple System Atrophy" (11 trials) and "Depression" (10 trials). Many other conditions were trialed in "Vanderbilt University" in a lesser frequency.

Most popular intervention types in "Vanderbilt University" are "Drug" (269 trials), "Other" (77 trials), "Device" (64 trials), "Behavioral" (52 trials) and "Biological" (52 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (79 trials), "placebo" (15 trials), "Botulinum toxin type A" (5 trials), "Cyclophosphamide" (4 trials) and "Fludarabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt University" are 523 trials for "All" genders, 14 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 124 active trials in "Vanderbilt University". 3 are not yet recruiting, 60 are recruiting, 56 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 336 completed trials in Vanderbilt University, undefined suspended trials, and 65 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt University, 68 "Phase 1" clinical trials were conducted, 148 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 135 trials that are defined as “Not Applicable".

Vanderbilt University has several departments that took part in Clinical trials: "Vanderbilt University School of Nursing" - 7 trials